- Home
- NUVB vs BFST Comparison
NUVB vs BFST Comparison
Compare NUVB & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- BFST
- Stock Information
- Founded
- NUVB 2018
- BFST 2006
- Country
- NUVB United States
- BFST United States
- Employees
- NUVB N/A
- BFST N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- BFST Major Banks
- Sector
- NUVB Health Care
- BFST Finance
- Exchange
- NUVB Nasdaq
- BFST Nasdaq
- Market Cap
- NUVB 679.9M
- BFST 783.9M
- IPO Year
- NUVB N/A
- BFST 2018
- Fundamental
- Price
- NUVB $2.50
- BFST $25.40
- Analyst Decision
- NUVB Strong Buy
- BFST Strong Buy
- Analyst Count
- NUVB 6
- BFST 3
- Target Price
- NUVB $7.83
- BFST $29.67
- AVG Volume (30 Days)
- NUVB 5.9M
- BFST 114.0K
- Earning Date
- NUVB 08-04-2025
- BFST 07-28-2025
- Dividend Yield
- NUVB N/A
- BFST 2.21%
- EPS Growth
- NUVB N/A
- BFST N/A
- EPS
- NUVB N/A
- BFST 2.43
- Revenue
- NUVB $10,957,000.00
- BFST $276,739,000.00
- Revenue This Year
- NUVB $98.78
- BFST $25.38
- Revenue Next Year
- NUVB $489.71
- BFST $10.72
- P/E Ratio
- NUVB N/A
- BFST $10.40
- Revenue Growth
- NUVB N/A
- BFST 11.75
- 52 Week Low
- NUVB $1.54
- BFST $20.07
- 52 Week High
- NUVB $3.97
- BFST $30.30
- Technical
- Relative Strength Index (RSI)
- NUVB 63.18
- BFST 49.77
- Support Level
- NUVB $2.06
- BFST $25.32
- Resistance Level
- NUVB $2.62
- BFST $26.63
- Average True Range (ATR)
- NUVB 0.15
- BFST 0.60
- MACD
- NUVB 0.04
- BFST -0.11
- Stochastic Oscillator
- NUVB 78.71
- BFST 18.10
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.